152 related articles for article (PubMed ID: 33582207)
1. Recommendations of the schizophrenia expert center network for the screening prevention and treatment of sleep disorders based on the results from the real-world schizophrenia FACE-SZ national cohort.
Sunhary de Verville PL; Etchecopar-Etchart D; Richieri R; Godin O; Schürhoff F; Berna F; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Leignier S; Mallet J; Misdrahi D; Passerieux C; Pignon B; Rey R; Urbach M; Vidailhet P; Leboyer M; Llorca PM; Lançon C; Boyer L; Fond G;
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110275. PubMed ID: 33582207
[TBL] [Abstract][Full Text] [Related]
2. Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohort.
Fond G; Bulzacka E; Boucekine M; Schürhoff F; Berna F; Godin O; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Leignier S; Lançon C; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Leboyer M; ; Boyer L; Llorca PM
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():8-18. PubMed ID: 30552914
[TBL] [Abstract][Full Text] [Related]
3. Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset.
Fond G; Boyer L; Favez M; Brunel L; Aouizerate B; Berna F; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq ; Faget C; Gabayet F; Laouamri H; Lancon C; Le Strat Y; Misdrahi D; Rey R; Passerieux C; Schandrin A; Schurhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Pelissolo A;
Psychopharmacology (Berl); 2016 Feb; 233(4):571-8. PubMed ID: 26630993
[TBL] [Abstract][Full Text] [Related]
4. [The 10-year findings from the FondaMental Academic Center of Expertise for Schizophrenia (FACE-SZ): Review and recommendations for clinical practice].
Schürhoff F; Fond G; Berna F; Bulzacka E; Godin O; Boyer L; Misdrahi D; Andrianarisoa M; Brunel L; Coulon N; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Gabayet F; Mallet J; Rey R; Lancon C; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Llorca PM;
Encephale; 2019 Feb; 45(1):9-14. PubMed ID: 30327207
[TBL] [Abstract][Full Text] [Related]
5. Precision-medicine findings from the FACE-SZ cohort to develop motivation-enhancing programs in real-world schizophrenia.
Korchia T; Tastevin M; Sunhary de Verville PL; Joober R; Andrieu-Haller C; Faugere M; Godin O; Etchecopar-Etchart D; Berna F; Aouizerate B; Capdevielle D; Chereau I; Clauss-Kobayashi J; Coulon N; Dorey JM; Dubertret C; Dubreucq J; Mallet J; Misdrahi D; Passerieux C; Rey R; Schürhoff F; Szoke A; Urbach M; Leboyer M; Llorca PM; Lançon C; Richieri R; Boyer L; Fond G
World J Biol Psychiatry; 2022 Nov; 23(9):703-714. PubMed ID: 35057713
[TBL] [Abstract][Full Text] [Related]
6. Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort.
Andrianarisoa M; Boyer L; Godin O; Brunel L; Bulzacka E; Aouizerate B; Berna F; Capdevielle D; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Llorca PM; Mallet J; Misdrahi D; Rey R; Richieri R; Passerieux C; Schandrin A; Tronche AM; Urbach M; Vidailhet P; Schürhoff F; Fond G;
Schizophr Res; 2017 Jul; 185():173-181. PubMed ID: 28109668
[TBL] [Abstract][Full Text] [Related]
7. Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort.
Fond G; Godin O; Schürhoff F; Berna F; André M; Aouizerate B; Capdevielle D; Chereau I; D' Amato T; Dubertret C; Dubreucq J; Faget C; Lançon C; Leignier S; Mallet J; Misdrahi D; Passerieux C; Pignon B; Rey R; Szoke A; Urbach M; Vidailhet P; Leboyer M; Boyer L; Llorca PM;
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109927. PubMed ID: 32173456
[TBL] [Abstract][Full Text] [Related]
8. Childhood trauma, depression, and sleep quality and their association with psychotic symptoms and suicidality in schizophrenia.
Kilicaslan EE; Esen AT; Kasal MI; Ozelci E; Boysan M; Gulec M
Psychiatry Res; 2017 Dec; 258():557-564. PubMed ID: 28916298
[TBL] [Abstract][Full Text] [Related]
9. Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set.
Fond G; Godin O; Brunel L; Aouizerate B; Berna F; Bulzacka E; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Strat Y; Micoulaud-Franchi JA; Misdrahi D; Rey R; Richieri R; Passerieux C; Schandrin A; Schürhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Leboyer M;
J Affect Disord; 2016 Feb; 191():209-15. PubMed ID: 26674214
[TBL] [Abstract][Full Text] [Related]
10. Psychometric assessment of subjective sleep quality using the Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J) in psychiatric disordered and control subjects.
Doi Y; Minowa M; Uchiyama M; Okawa M; Kim K; Shibui K; Kamei Y
Psychiatry Res; 2000 Dec; 97(2-3):165-72. PubMed ID: 11166088
[TBL] [Abstract][Full Text] [Related]
11. Major depression, sleep, hostility and body mass index are associated with impaired quality of life in schizophrenia. Results from the FACE-SZ cohort.
Fond G; Korchia T; Sunhary de Verville PL; Godin O; Schürhoff F; Berna F; André M; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Leignier S; Mallet J; Misdrahi D; Passerieux C; Pignon B; Rey R; Szoke A; Urbach M; Vidailhet P; Leboyer M; Llorca PM; Lançon C; Boyer L;
J Affect Disord; 2020 Sep; 274():617-623. PubMed ID: 32663995
[TBL] [Abstract][Full Text] [Related]
12. Effects of chlorpromazine on sleep quality, clinical and emotional measures among patients with schizophrenia.
Meng Q; Li R; Hou F; Zhang Q
Clin Neurol Neurosurg; 2018 Feb; 165():134-138. PubMed ID: 29421173
[TBL] [Abstract][Full Text] [Related]
13. Latent toxoplasma infection in real-world schizophrenia: Results from the national FACE-SZ cohort.
Fond G; Boyer L; Schürhoff F; Berna F; Godin O; Bulzacka E; Andrianarisoa M; Brunel L; Aouizerate B; Capdevielle D; Chereau I; Coulon N; D'Amato T; Dubertret C; Dubreucq J; Faget C; Lançon C; Leignier S; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Leboyer M;
Schizophr Res; 2018 Nov; 201():373-380. PubMed ID: 29843964
[TBL] [Abstract][Full Text] [Related]
14. Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort.
Mallet J; Le Strat Y; Schürhoff F; Mazer N; Portalier C; Andrianarisoa M; Aouizerate B; Berna F; Brunel L; Capdevielle D; Chereau I; D'Amato T; Dubreucq J; Faget C; Gabayet F; Honciuc RM; Lançon C; Llorca PM; Misdrahi D; Rey R; Roux P; Schandrin A; Urbach M; Vidailhet P; Fond G; Dubertret C;
Eur Arch Psychiatry Clin Neurosci; 2019 Jun; 269(4):449-457. PubMed ID: 29396753
[TBL] [Abstract][Full Text] [Related]
15. Hypovitaminosis D is associated with depression and anxiety in schizophrenia: Results from the national FACE-SZ cohort.
Fond G; Godin O; Schürhoff F; Berna F; Bulzacka E; Andrianarisoa M; Brunel L; Aouizerate B; Capdevielle D; Chereau I; Coulon N; D'Amato T; Dubertret C; Dubreucq J; Faget C; Lançon C; Leignier S; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Leboyer M; Boyer L; Llorca PM;
Psychiatry Res; 2018 Dec; 270():104-110. PubMed ID: 30245372
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory DEpression Advances in Schizophrenia (IDEAS): A precision medicine approach of the national FACE-SZ cohort.
Fond G; Godin O; Schürhoff F; Berna F; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Leignier S; Lançon C; Mallet J; Marulaz L; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Leboyer M; ; Boyer L; Llorca PM
J Affect Disord; 2019 Feb; 245():468-474. PubMed ID: 30428447
[TBL] [Abstract][Full Text] [Related]
17. The impact of parent history of severe mental illness on schizophrenia outcomes: results from the real-world FACE-SZ cohort.
Garosi A; Sunhary de Verville PL; Etchecopar-Etchart D; Richieri R; Godin O; Schürhoff F; Berna F; Aouizerate B; Capdevielle D; Chereau I; Clauss-Kobayashi J; Dorey JM; Dubertret C; Coulon N; Leignier S; Mallet J; Misdrahi D; Passerieux C; Rey R; Szoke A; Urbach M; Leboyer M; Llorca PM; Lançon C; Boyer L; Fond G;
Eur Arch Psychiatry Clin Neurosci; 2023 Jun; 273(4):825-837. PubMed ID: 35852617
[TBL] [Abstract][Full Text] [Related]
18. Sexual dysfunctions are associated with major depression, chronic inflammation and anticholinergic consumption in the real-world schizophrenia FACE-SZ national cohort.
Fond G; Godin O; Dumontaud M; Faget C; Schürhoff F; Berna F; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Leignier S; Mallet J; Misdrahi D; Passerieux C; Rey R; Schandrin A; Szoke A; Urbach M; Vidailhet P; Leboyer M; Lançon C; Boyer L; Llorca PM;
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Aug; 94():109654. PubMed ID: 31125587
[TBL] [Abstract][Full Text] [Related]
19. Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set.
Fond G; Berna F; Boyer L; Godin O; Brunel L; Andrianarisoa M; Aouizerate B; Capdevielle D; Chereau I; Danion JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Gloahec T; Llorca PM; Mallet J; Misdrahi D; Rey R; Richieri R; Passerieux C; Portalier C; Roux P; Vehier A; Yazbek H; Schürhoff F; Bulzacka E;
Eur Arch Psychiatry Clin Neurosci; 2018 Feb; 268(1):17-26. PubMed ID: 28349247
[TBL] [Abstract][Full Text] [Related]
20. Fatigue, sleep-wake pattern, depressive and anxiety symptoms and body-mass index: analysis in a sample of episodic and chronic migraine patients.
Lucchesi C; Baldacci F; Cafalli M; Dini E; Giampietri L; Siciliano G; Gori S
Neurol Sci; 2016 Jun; 37(6):987-9. PubMed ID: 26879311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
